Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fezakinumab in Atopic Dermatitis
NCT01941537Phase 2Completed
- Sponsor
- The Rockefeller University
- Start
- Oct 2013
- Primary completion
- Feb 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of fezakinumab in atopic dermatitis (AD), sponsored by The Rockefeller University. Started Oct 2013; status: completed.
02
Drugs
fezakinumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01941537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941537.